|
|
Study on medication rules of traditional Chinese medicine in treating infantile asthma based on literatures mining |
REN Yuzhe1 YU Zhou1 CHEN Hong2 YANG Zeyi3 PENG Xuejin1 YANG Xiangzheng1 |
1.Department of Pediatrics, Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang), Guangdong Province, Shenzhen 518100, China;
2.Department of Pediatrics, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
3.School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China |
|
|
Abstract Objective To find out the medication rules of traditional Chinese medicine in treating infantile asthma and analyze the network by data mining. Methods The literatures of China National Knowledge Infrastructure (CNKI) from January 2009 to December 2019 were organized, with the theme of “pediatric asthma” and “Chinese medicine”, and the statistics were made on Chinese medicine treatment rules, traditional Chinese medicine compound dosage forms, combined use of Western medicine. The frequency statistics, drug pair statistics and the extraction and sorting of the main compatibility relationship of traditional Chinese medicine for treating pediatric asthma were carried out by Bibexcel analysis software. A visual network was built by NetDraw in Ucinet 6.0 software. Results From the statistical results, the traditional Chinese medicine compound dosage forms for treating pediatric asthma were mainly decoctions, patches, plasters and pastes. Western medicine was mostly combined with glucocorticoids and traditional Chinese medicine. The main treatment of traditional Chinese medicine for pediatric asthma was “ventilating lung qi and suppressing dyspnea”, “suppressing dyspnea and relieving cough”, and the drugs with the flavours of “bitter, sweet, pungent” and the nature of “cold, warm, clam”, and mostly belong to “lung, spleen, kidney” were mainly used. The most frequently used drug was ephedra (63 times), the most frequently used drug pair was ephedra and bitter apricot seed (43 times). In network relationship compatibility, ephedra, milkvetch root, earthworm, white mulberry root-bark and bitter apricot seed were all located at the center point. Conclusion At present, the treatment of pediatric asthma tends to choose a topical dosage form with high compliance. The main treatments are “ventilating lung qi”, “suppressing dyspnea” and “relieving cough”, and mainly use the drugs of superficies-relieving, dissipating phlegm, relieving cough and suppressing dyspnea. The data mining of medication rules of traditional Chinese medicine for pediatric asthma has guiding significance for clinical medicine, and has certain value for the inheritance and development of traditional Chinese medicine.
|
|
|
|
|
[1] Balenghien T,Cardinale E,Chevalier V,et al. Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean [J]. Vet Res,2013,44(1):78.
[2] 李星慧,钟峰,曹越,等.基于数据挖掘浅析穴位贴敷治疗支气管哮喘的药物组成规律[J].上海针灸杂志,2019, 38(7):806-811.
[3] 梁伍今.柴麻止哮胶囊配合西药治疗老年支气管哮喘急性发作期的临床研究[J].中国老年学杂志,2008,28(17):1749-1750.
[4] 杨福双,王中天,孙丽平.基于中医传承辅助系统分析中医药治疗儿童哮喘发作期的用药规律[J].中国中医基础医学杂志,2019,25(8):1078-1081.
[5] 常佳婧,何院生,高凌,等.基于Aprior等统计法分析儿童哮喘发作期痰哮证和外寒内热证中药用药规律[J].时珍国医国药,2019,30(1):250-252.
[6] 国家药典委员会.中国药典[S].一部.北京:中国医药科技出版社,2015.
[7] 杜丽东,田金徽,吴国泰,等.基于文献的中药治疗便秘的社会网络分析[J].中国中药杂志,2017,42(2):370-377.
[8] 刘波.统计对比88例支儿童气管哮喘应用中西医联合用药疗效优势于单纯西医治疗[J].中国保健营养,2012, 22(14):2939-2940.
[9] Aschenbrenner DS. Over-The-Counter Asthma Inhaler Returns to the Market [J]. Am J Nurs,2019,119(3):20-21.
[10] 赵霞,汪受传,韩新民,等.小儿哮喘中医诊疗指南[J].中医儿科杂志,2008,4(3):6-8.
[11] 张晓华,赵霞.小儿哮喘中医复方研究的现状及与药物遗传学的相关性探讨[J].中国中医急症,2016,25(5):854-857.
[12] 黄柳明.基于微信平台的延续护理对学龄哮喘患儿生活质量和依从性的影响[J].中外医疗,2019,38(13):130-132.
[13] 于志芳.中药敷脐治疗儿童哮喘疗效观察与护理[J].中国农村卫生事业管理,2009,29(8):635-636.
[14] 董文芳.儿童哮喘控制联合用药的选择[J].临床儿科杂志,2011,29(9):891-894.
[15] 汤正珍,郑跃杰.吸入糖皮质激素治疗哮喘儿童5年后回顾性研究[J].中国微生态学杂志,2013,25(8):931-935,938.
[16] 梁额尔敦.治疗小儿支气管哮喘经验[J].中国现代药物应用,2009,3(24):124-125.
[17] 张岩,赵坤.赵坤教授从痰治疗小儿哮喘的经验[J].现代中医临床,2008,15(2):122-124.
[18] 黄晓帅,王明明.小儿哮喘病因病机研究[J].吉林中医药,2011,31(2):128-129.
[19] 陈禧.“纯阳”之体及其儿科临床意义[J].中医儿科杂志,2010,6(2):1-2.
[20] 吕晓武,吴丽萍,史正刚.张士卿教授从痰瘀辨治小儿哮喘的用药经验[J].中医儿科杂志,2013,9(3):1-3.
[21] 许杰红,曹厚然,陈玉兴.中药单剂炙麻黄、麻黄对哮喘大鼠气道炎症反应的影响[J].新中医,2014,46(12):197-199.
[22] 付俊华,朱祝生.麻黄汤治疗哮喘机理研究[J].江西中医药,2008,39(2):57-58.
[23] 王娇,王宋平.麻黄及其汤剂治疗哮喘的研究进展[J].四川中医,2010,28(9):35-38.
[24] Han HY,Huh JI,Han SR,et al. Assessing the safety of an EphedraeHerba aqueous extract in rats:A repeat dose toxicity study [J]. Regul Toxicol Pharm,2018,94(5):144-151.
[25] 魏萍.中药苦杏仁治疗哮喘的研究[J].内蒙古中医药,2017,36(15):132-133.
[26] 邹澍,武国忠.本经疏证[M].海口:海南出版社,2009. |
|
|
|